Tag: drug development

April 22, 2022
Phase 2 Trials for Non-Opioid Pain Medication Deliver Promising Results

VX-548 delivered significant improvements in pain with few adverse events.

READ MORE
January 15, 2022
Additional Vaccine Candidate Performs Well in Clinical Trials

Phase 3 trials for NVX-CoV2373 across 30,000 people found this vaccine candidate to be safe and effective for the prevention of COVID-19.

READ MORE
April 14, 2020
FDA Diagnostic Testing Updates

The FDA is working to expedite the delivery of diagnostic testing for COVID-19.

READ MORE
March 18, 2020
COVID-19 and Clinical Trials

COVID-19 drug trials are underway, but the pandemic is disrupting clinical testing.

READ MORE
August 10, 2018
FDA Accepts New Drug Application for Opioid NKTR-181

NKTR-181 is supposed to offer a lower frequency of opioid side effects. But are more opioids really the solution we need to the opioid crisis?

READ MORE
August 4, 2018
New Developments in Migraine Medications

A new wave of drugs that suppress CGRP proteins to reduce migraines could be on the horizon.

READ MORE
August 2, 2018
FDA Proposes New Clinical Endpoints for Development of Opioid-Use Disorder Drugs

Drugs to treat opioid dependence could be approved under new clinical endpoints other than reducing opioid use.

READ MORE
March 10, 2018
FDA Approves New Opioid Prodrug, Apadaz

Apadaz oral tablets were approved for the short-term management of acute pain, at no more than 14 days of use.

READ MORE
lockenvelopephone-handsetmenucross-circle